Abstract
Reverse-phase evaporation vesicles (REV), which have been proposed for use as drug carriers, were evaluated for stability in human plasma. A kinetic study of carboxyfluorescein (CF) leakage from REV showed that plasma caused an initial burst of CF leakage, followed by apparent recovery of the barrier function of REV membrane. The rate of phospholipid exchange between REV and high-density lipoprotein, and the changes in the turbidity of REV and in the polarization of a fluorescent probe embedded in the membrane during the incubation of REV in plasma were determined. On the basis of the results, it is suggested that the interaction of REV and plasma initially increased the permeability of REV membrane, resulting in the formation of REV with a smaller volume of water phase, and these REV were no longer susceptible to the destabilizing effect of plasma.
- Received July 29, 1984.
- Accepted November 1, 1984.
- Copyright © Parenteral Drug Association. All rights reserved.
PDA members receive access to all articles published in the current year and previous volume year. Institutional subscribers received access to all content. Log in below to receive access to this article if you are either of these.
If you are neither or you are a PDA member trying to access an article outside of your membership license, then you must purchase access to this article (below). If you do not have a username or password for JPST, you will be required to create an account prior to purchasing.
Full issue PDFs are for PDA members only.
Note to pda.org users
The PDA and PDA bookstore websites (www.pda.org and www.pda.org/bookstore) are separate websites from the PDA JPST website. When you first join PDA, your initial UserID and Password are sent to HighWirePress to create your PDA JPST account. Subsequent UserrID and Password changes required at the PDA websites will not pass on to PDA JPST and vice versa. If you forget your PDA JPST UserID and/or Password, you can request help to retrieve UserID and reset Password below.